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TABLE I. BIRTHWEIGHT OF GESTATIO 'ALLY MAT RE I 'FAf'o'TS BORN
TO 92 DIABETIC MOTHERS 0 ' NO TREATMENT
TABLE 11. PERINATAL MORTALITY I RELATIO TO BIRll-fWEIGHT:
AN ANALYSIS OF 167 DIABETIC PREGNA ClES
Birthweight (lb.) <6 6-7 7-8 8>
Tumber 37 41 45 45
Stillbirths and
neonatal deaths 11 1 3 5
Perinatal loss ~~ 30·5 2-4 6·6 11·1
(13·8 corrected)
These babies were delivered between the 37th and 38th
weeks of gestation, and, with the exception of one till birth
resulting from an abruptio placentae, all were born alive.
The significance of the diabetic baby which is mall
according to dates is best appreciated when one considers
the perinatal mortality rate in relation to birthweight.
Of the 167 atal Indian diabetics delivered during the
past 4 years (see Table II), 36 babies weighed less than
6 lb., 41 were between 6 and 7 lb. 45 between 7 and 8 lb.,
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death rates (with the numbers involved in parenthe i )
were 30'5°~ (11); 2·4% (1); 6'6°~ (3); and 11'lo~ (5).
However, of the 11 infants below 6 lb. who died, 2 were
definitely born prematurely according to dates; one died
as a result of abruptio placentae; 2 were as ociated with
evere toxaemia and one with maternal hyperpyrexia due
to recurrent pyelonephritis.
The remaining 5 (or 13'8°~) were either stillborn or were
associated with gross foetal di tress resulting in neonatal
death. In no instance was there any ignificant factor
which could have accounted for the perinatal death.
Thu , in our eries the perinatal loss of the babie that
were mall according to dates. resulting from pregnancie<;
\\hich were otherwi e clinically normal and of calculated
tion of maternal diabetes, while Pederson lO has more
recently confirmed that some diabetic babies can be
described as small according to dates. It mu t be empha-
sized, however, that this decrease in birthweight is not
related to that following prolonged ho pitalization" but i
attributed to panvascular lesion which are clinically
detectable and definable according to varying grade of
severity.'
In our unit I have noted a similar trend-particularly in
pregnancies complicated by severe toxaemia-but regard
as of even greater significance the fact that babies that are
small according to dates are frequently born to mothers
without any obvious evidence of vascular disease or com-
plications associated with diabetes.
Thus, of 92 proved diabetics (see Table ]) who had
received no treatment other than bed rest and dietary
restriction alone, no fewer than 16'3°~ gave birth to
infants weighing less than 6 lb.
"'Paper presented at the Interim Congress of the ~outh African ociety of
Obstetricians and Gynaecologi ts, Hermanus, Apnl 196 .
The obstetrician's contribution to the improved perinatal
survival resulting from diabetic pregnancies centres on
antenatal supervision and hospitalization, planned termina-
tion of the pregnancy before the expected date of confine-
ment and improved methods of delivery.
Of these three facets, it is the decision of when to induce
labour which is most liable to error, and which therefore
constitutes the weakest link in the obstetrician's therapeutic
armamentarium.
The following contribution is based on the experience
gained in the personal supervision of over 150 pregnant
diabetics and is presented with the primary object of
describing certain features regarding the diabetic baby.
The treatment differs in many respects from generally
accepted practice, and is intimately bound with the obstetri-
cian's dilemma of when and how to deliver the pregnant
diabetic.
THE SMALL DIABETIC BABY
Although most pregnant diabetics are seen at an early
stage of pregnancy, the same is not true of the atal
Indian diabetic. Late and irregular attendance at the ante-
natal clinics, together with illiteracy, frequently results in
inconsistencies between the menstrual history and the
clinical assessment of the expected duration of the preg-
nancy. Consequently, the tendency to correlate the esti-
mated size of the baby with gestational maturity became
the accepted practice in our unit. This, however, posed 2
queries, namely, does foetal maturity equate with foetal
size; and, are diabetic babies always large?
In 1947, McBurney' drew attention to the under-
nourished full-term baby, and demonstrated that it was
incorrect to call a baby 'premature' simply because its
birthweight was low. The World Health Organization
Expert Committee' subsequently recommended that babies
with birthweights of 5t lb. or less should in future be
called 'low birthweight babies' rather than premature
babies, thus confirming the concept of a gestationally
mature baby which appears small according to the date.'"
Recognition of this condition is of importance for the
following 3 reasons:
(a) It occurs frequently-no fewer than 35°{, of low
birthweight babies born during the recent perinatal mor-
tality survey· were found to be gestational1y mature.
(b) The perinatal death rate of such infants is high,
'the major component being stillbirth and intra-uterine
death of the fade-out variety'.'
(c) Whereas a clinical cause for poor growth can be
found in over 80% of prematurely born babies, only 40%
of pregnancies with babies that are small according to the
date have some clinical1y detectable abnormality.'
By contrast, the pathognomonic picture of the diabetic
baby is one of a premature, but large overweight infant.
Although this is true for the majority of diabetic babie ,
Hsia and Gellis,' and White' have noted a decrease in
birthweight with the progression of the severity and dura-
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maturity, exceeded that of the typical diabetic baby which
is large in relation to the date-13'8~~ versus 11.1 0 0.
Why are Diabetic Babies Small?
Acceptance of this concept is of little practical value, if
the underlying cause cannot be explained or determined.
Reference to the non-diabetic small infant reveals
histological maturity of the vital pulmonary and renal
structures, the small birthweight being due to a low total
infant weight associated with a correspondingly small
placenta." The pathogenesis of these infants-while not
conclusively established-is said to be due to impairment
in the maternal vascular supply: As mentioned earlier, a
similar situation exists among the long-term diabetic
mothers with panvascular lesions:
However, a recent report from the Joslin Clinic"
established that maternal vascular disease in pregnant
diabetics is far more common than was previously
acknowledged. No fewer than 20 - 50% of decidual biopsy
specimens taken from diabetic subjects (with or without
other clinical evidence of vascular disease) were found to
have angiopathic changes. There is therefore little reason
why the same cannot hold true for the Natal Indian
diabetic who produces a small diabetic baby, particularly
when one appreciates that the Natal Indian diabetics, as a
group, are prone to vascular disease.H
Can the Small Diabetic Baby be Predicted?-A Hypothesis
It is known that characteristic vascular changes occur in
the intimal lining of vessels taken from biopsy specimens
of ear-lobes in diabetic and prediabetic subjects." If it can
be shown that similar lesions in pregnant diabetics reflect
equivalent changes in the pelvic vasculature, a practical
and accurate diagnostic method would be available for
use, both as a clinical guide and as a yardstick for prog-
nosis.
Thus, on the basis of positive biopsies of skin or muscle,
it will be possible to predict which diabetic women are
liable to produce small diabetic babies so that planned
termination of pregnancy will not be withheld because of
a clinically small baby.
Study into this aspect is to be initiated in the near future.
THE LARGE DIABETIC BABY
Blood-Sugar Level and Foetal Size
Foetal overgrowth and overweight are nevertheless the
characteristic features of the foetus and infant born to the
diabetic mother. Of the many theories regarding the
pathogenesis of these features, the maternal hyperglycae-
mia/foetal hyperinsulinism theory is probably the most
popular." Expressed in simple terms, this hypothesis sug-
gests that maternal hyperglycaemia results in foetal hyper-
glycaemia, and that the latter causes hypertrophy of the
foetal islet tissue with insulin hypersecretion. This allows
for greater foetal utilization of glucose and augments the
deposition of glycogen and fat. In support of this theory
Pederson" found that the birthweight of infants born to
mothers with Iow blood-sugar levels was (on an average)
150 G less than that of infants whose mothers were poorly
controlled.
However, Hagbard" and Jackson" do not accept this
theory, as islet cell hypertrophy is often demonstrable in
infants born to mothers many years before diabetes is
recognized, while poorly controlled diabetics do not
necessarily produce large infants with islet hypertrophy.
This has also been my experience and is illustrated by
typical examples.
An infant born to patient A.c. weighed 9 lb. 15 oz. at birth.
The maternal blood-sugar level varied between 130 and 150
mg.{IOO m!. and the patient was well controlled on 20 units
lente insulin per day.
A second infant resulted from a poorly controlled diabetic
pregnancy with postprandial blood-sugar levels usually above
200 mg.{IOO m!., the patient ( . T.) requiring 200 units of
insulin per day. The infant weighed 6 lb. 15 oz. at birth.
Gestational ages were the same in both instances and there
was no clinical evidence of vascular disease in either patient.
Many similar examples have been noted and it is there-
fore my opinion that elevated maternal blood-sugar levels
per se do not necessarily account for foetal overgrowth.
Conversely, it would be logical to conclude that the foetal
size is more closely related to the factor(s) which is
responsible for the maternal hyperglycaemia, and not vice
versa. The cause for the foetal overgrowth can therefore
be expected to differ with the aetiology of the underlying
metabolic disturbance in individual patients. In this regard
it is pertinent to note that the degree of diabetic control (as
judged by postprandial blood-sugar levels) did not influence
the adrenocortical function of our pregnant diabetics with
proved hyperactivity."
Lipid Metabolism and Birthweight
Whereas disagreement exists as to the cause of diabetic
embryopathy, it is now generally agreed that these infants
are fat rather than oedematous. OsIer," for example, found
a 38 - 46~~ increase in the subcutaneous fat layer.
During a recent random-sample therapeutic trial," it was
noted that the birthweights of infants born to mothers on
treatment with the sulphonylureas were significantly lower
than those whose mothers had received either insulin or no
specific antidiabetic therapy (Table Ill).
TABLE Ill. COMPARISO OF BIRTHWEIGHT OF INFANTS BORN
ON A RANDOM-SAMPLE THERAPEUTIC STUDY
Treatment Normal
controls Rastinon Diabinese Insulin Diet
Number 200 29 26 28 24
Mean weight (lb.) 6·38 6·58 6·99 7·65 7'50
SD 1·20 1·05 1·31 2'12 1·03
'F' test for statistical ,ignificance P = <0·01 (F = 9·69).
The mean birthweight of the babies whose mothers had
received tolbutamide was 6·58 lb., as compared with 6'99,
7·65 and 7·50 lb. for patients treated with chlorpropamide,
insulin and dietary restriction alone.
The significance of these results may be related to the
conclusions of a recent study (based on well-documented
experimental work) which suggested that the elevated
maternal free fatty acids commonly found in diabetic
pregnancies led to a greater net transfer of free fatty acids
into the foetal circulation, and that this was responsible for
the increased body-fat content of the diabetic baby. If these
findings are extrapolated to human beings, a plausible
explanation for the observed lower weight of the infants
born to sulphonylurea-treated mothers can be established,
as the sulphonylureas have recently been found to induce
a significant decrease in the net release of fatty acids from
adipose tissue.'"
If, in addition, a recent hypothesis" regarding the pro-
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duction of foetal arteriosclerosis and metabolic acidosis
subsequent to increased maternal free fatty acid meta-
bolism is proved to be correct, the indications for the use
of the sulphonylureas should be extended to include all
pregnant diabetics, since the sulphonylureas are known to
cross the placentai barrier, and would exert their beneficial
antilipid effect in the foetus.
It is well documented that typical 'diabetic-hke' babies
are delivered many years before the onset of overt diabetes
and that elevated free fatty acid levels are frequently found
before demonstrable abnormalities in carbohydrate meta-
bolism.~' Furthermore, the concentration of the plasma free
fatty acids normally rises during pregnancy," while both
growth hormone"',03 and cortisone" (factors which are in-
creased during pregnancy) increase plasma free fatty acids.
Abundant evidence therefore exists to stimulate a re-
appraisal of the role and possible value of the antilipid
effect of the sulphonylureas in the treatment of the preg-
nant diabetic, as control of abnormal lipid metabolism
may help to reduce the incidence of the so-called 'unavoid-
able foetal death'."
CLINICAL MANAGEMENT
The clinical importance of the small diabetic baby lies in
the fact that size does not necessarily correlate with the
foetal maturity and that an unwarranted prolongation of
its intra-uterine existence, in an attempt to deliver a larger
baby, will frequently result in perinatal loss.
The obstetrician's dilemma therefore resolves to one of
assessing foetal maturity and growth as against placental
function and reserve.
Foetal Maturity
Clinical assessment. Early and frequent attendance at
antenatal clinics usually allows for accurate assessment and
follow-up of the duration of pregnancy. However, when
this is not available, reliance must be placed on abdominal
palpation, in order to determine both the height of the
fundus and foetal size.
Whereas the most reliable method of assessing foetal
size in the non-diabetic subject is to gauge the weight
according to the size of the presenting vertex, the same
does not hold true for the diabetic. Abdominal palpation
frequently leads to an underestimation of the baby's ex-
pected weight, for the brain of the diabetic infant is known
to be smaller than that of the gestationally equivalent
normal baby." We have been cognizant of this feature
for some time and therefore advocate that allowance be
made for this discrepancy; a combined abdominal and
pelvic examination allows for greater accuracy in this
respect and is particularly helpful in the presence of
hydramnios.
Radiological assessment. Although the accuracy of the
radiological assessment of foetal maturity has been ques-
tioned in recent times, we still employ and advocate the
procedure, for apart from being a guide to maturity it
enables one to exclude the presence of skeletal abnormali-
ties and to look for evidence of pelvic vascular calcifica-
tion.
Our procedure is supported by a recent prospective
study'" which concluded that a distal femoral epiphysis was
radiologically detectable in 96°~ of mature foetuses. When
present in association with a vi ible proximal tibial epiphy-
SIS as well, the indication of phy iological foetal maturity
IS even more reliable." Radiological cephalometry, how-
ever, is not particularly helpful, for although the biparietal
diameter of the foetal head bear a clo e relation hip to the
weight, it i only possible to asses the foetal head for thi
purpo e in approximately 33 0 0 of ca es.'" We ne erthele s
regard the presence of a well-developed cortical kull bone
as a sign of advanced foetal maturity, cognizant of the fact
that it is not in itself a reliable ign of maturity.
Foetal Growth
Clinical assessment. The clinical as essment of foetal
growth is both difficult and variable. Daily palpation im-
parts an impression of progressive foetal growth, and it i
failure to observe this feature which is often the first
detectable sign that foetal growth i retarded. everthele,
it remains a clinical guide rather than a reproducible
definitive parameter.
Ultrasonics. Ultrasonics provides the most effective means
of measuring foetal growth, as it can be safely repeated, at
frequent intervals, to assess the growth rate of the biparie-
tal diameter, and therefore of the infant. For example,
failure to progress (in the presence of a clinically small
baby) would indicate the need for obstetrical interference.
Unfortunately this device is not available at the King
Edward VIn Hospital, but it certainly merit further tudy
and use in everyday clinical practice.
Placental Function
It is generally agreed that placental function is be t
assessed by measuring the oestriol excretion rate."'''''' A
recent study" has in fact confirmed that:
(a) high oestriol levels during pregnancies complicated
by diabetes are associated with good foetal prog-
noses, whereas low levels offer a poor prognosis;
(b) oestriol levels can be used for the prediction of the
weight of the newborn ;
(c) they can provide information concerning the growth
of the foetus in utero;
(d) 2 consecutive (daily) falling value are indicative of
foetal death and justify immediate termination of
the pregnancy.
Since laboratory facilities for the biological estimation
of oestrogen are not always available, we hope to correlate
the cornification index in our diabetic patients with placen-
tal function. Weekly vaginal smear are obtained and
screened by the same cytologist. The results are then
assessed according to 2 criteria, namely the cornification
index itself (below 5°~ is indicative of good,S· 100~
satisfactory and 100,0 or more sugge tive of poor placen-
tal function) and the serial pattern-a progressi e ri e in
the cornification index being indicative of failing placental
activity. This will be correlated with oestriol excretion
values.
Insufficient data are at present available to formulate
any firm conclusions, but it is hoped that this technique,
together with other clinical ob ervation of placental
function-such a the bedside asses ment of the volume
of liquor, daily weight and girth mea urements-will form
useful adjunctive guides in the management of the preg-
nant diabetic.
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TABLE IV. PERINATAL LOSS AND MODE OF DELIVERY IN
132 ATAL INDIAN PATIENTS
TABLE V. PERINATAL MORTALITY RATE OF SMALL DIABETIC BABIES
I ' RELATIO ' TO MODE OF DELIVERY
MODE OF DELIVERY AND PERINATAL LOSS
Vaginal delivery is preferred by some authors as it is said
to have the advantage of reducing the incidence of respira-
tory distress in the infant. It has been our experience,
however, that the mode of delivery per se does not alter
foetal survival, provided that the correct indications are
employed. Thus, primary caesarean section is advocated
in the presence of complications such as toxaemia, cephalo-
pelvic disproportion, malpresentations, previous caesarean
section, poor obstetrical history and an inadequately con-
trolled diabetic state. Evidence of retinopathy, renal or
vascular disease, and foetal distress (meconium staining of
the liquor or irregularities in the rate and rhythm of the
foetal heart rate) is further indication for abdominal
delivery.
Induction of labour and vaginal delivery are attempted
in both primiparae and multiparae, provided the above
features are not present, cephalopelvic disproportion has
been excluded and the vertex is well applied to the cervix.
Table IV summarizes the method of delivery and the
associated perinatal loss. Equal numbers of patients were
delivered vaginally and by caesarean section (66 in each
group). Of infants delivered vaginally, 6 stillbirths and
no neonatal deaths were recorded, whereas there were 9
deaths following caesarean section: 3 were stillborn and 6
died neonatally. It might appear that diabetic babies born
by caesarean section are more prone to die neonatally than
those delivered vaginally. However, 5 of these 6 deaths
are directly attributable to causes unrelated to the opera-
tive procedure-prolapsed cord, Fallot's tetralogy, placenta
praevia, gross foetal distress and prematurity. The sixth
neonatal death resulted from a breech delivered by caesa-
rean section, and is the only possible instance where
anaesthesia or the operative procedure might have contri-
buted to the perinatal loss.
Fifty-six of the caesarean sections were performed under
general anaesthesia without noticeable adverse effect on
the infant at birth. The remaining 10 patients were de-
livered under epidural block or local infiltration plus
sedation with pethidine. In one instance, epidural block
was followed by such a profound fall in blood pressure
that the Apgar rating of the infant at birth was only 2.
A similar result is obtained when the perinatal loss of
the small diabetic baby is measured in relation to the
mode of delivery (Table V). Thus, the corrected perinatal
mortality following caesarean section was 9·1 % as com-
pared with 12·5% of those who were delivered vaginalIy-
a difference of no statistical significance.
As a result of this experience I feel that both caesarean
section and general anaesthesia are perfectly safe for
delivery of the diabetic baby, provided that the usual pre-
cautions associated with these procedures are observed.
SUMMARY
A brief resume of my experience in the antenatal management
of the baby of the diabetic mother is presented. As a result it
may be concluded that:
(a) Diabetic babies need not be large according to dates.
The pregnant diabetic produces infants which are frequently
gestationally mature but are of low birthweight. The perinatal
mortality of these infants is high and is invariably related to
an unwarranted prolongation of their intra-uterine existence in
an attempt to deliver a larger baby.
(b) The pathogenesis of the large diabetic baby is not
necessarily related to the maternal blood-sugar level. Closer
attention should be paid to the cause of the hyperglycaemia
or to abnormalities in lipid metabolism, for the therapeutic
consideration of these aspects may help to reduce the inci-
dence of 'unavoidable' foetal deaths.
(c) The clinical detection and management of the small
diabetic baby and the large diabetic baby are dependent upon
close antenatal supervision, clinical acumen, and other ancillary
methods of assessing foetal maturity, foetal growth and
placental function. The importance of the last 3 factors in
determining the time of termination of the pregnancy is
emphasized.
(d) Provided strict criteria are adopted, the mode of
delivery per se does not appear to affect the perinatal mor-
tality rate adversely.
I wish to thank Or H. Wannenburg, Medical Superintendent
of King Edward VllI Hospital, for permission to publish. This
study was sponsored by a generous grant from Messrs Pfizer
Ltd.
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